The mechanism proposed in this study, where ZFAS1 interacts with IGF2BP2 to stabilize STAT3 mRNA and promote its expression, provides a novel insight into the regulation of STAT3 in the context of CML drug resistance (40). Here, IGF2BP2 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.